Role of liver biopsy in management of chronic hepatitis C: a systematic review. - Wikidata - awgldk - TriplyDB

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

http://www.wikidata.org/entity/Q34984098

about

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)Four-dimensional flow magnetic resonance imaging in cirrhosis.Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.Ultrasound in chronic liver disease.Invasive and non-invasive diagnosis of cirrhosis and portal hypertension Liver elastography, comments on EFSUMB elastography guidelines 2013.Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis How efficient is acoustic radiation force impulse elastography for the evaluation of liver stiffness?Is ARFI elastography reliable for predicting fibrosis severity in chronic HCV hepatitis?Advanced MRI methods for assessment of chronic liver disease Meta-analyses of FibroTest diagnostic value in chronic liver disease.Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.Liver biopsy for histological assessment: The case in favor Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children.FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link.Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.Hepatitis infection in the treatment of opioid dependence and abuse."Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C.Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C.Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection.Why, who and how should perform liver biopsy in chronic liver diseases.Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection Carbohydrate 19.9 antigen serum levels in liver disease.Assessment of liver fibrosis: noninvasive means.An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients.Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index.Mini-laparoscopy in the endoscopy unit: Safety and outcomes in over one thousand patients.An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis.Non-biopsy methods to determine hepatic fibrosis.Clinical Utility of Biomarkers of Liver Fibrosis.Applicability and variability of liver stiffness measurements according to probe position.

P2860

Q24563264-F9C50A54-C6AC-452F-AF07-EE98F83CB5D5 Q24802436-3AEA42C9-E080-4C27-9C30-EBEBCB3DE2B8 Q26769606-6C3F82C0-3890-4D10-82E8-4D6ADF241743 Q26773289-93695DBE-35F7-41E0-AEAA-DC36B18C47F3 Q26777916-3230A868-3562-4F63-AA52-67A06029F345 Q28070280-F2F7326E-5FB9-46DD-9CFF-E622B55D6677 Q28484313-2D359A13-F242-4CC7-B527-948D5A8BE9D3 Q30422199-5EE3F59C-CB95-4333-A2AD-F36AEAC0BBB6 Q30432218-E59B70A4-5DE0-4094-9E6D-B8C421C4B661 Q30439743-2FF2E9F4-443E-4267-BE8B-FF1D2759761E Q30448132-3F42D17D-6FAF-433D-93B5-136A36039CD0 Q30470750-811CF653-9620-45DC-B0F2-63D47A9E298A Q30472901-D4C11547-F9D8-4239-8E50-F710D79457B1 Q30474480-D4365045-CFBE-44DE-B223-A7A3B6C764C7 Q30478601-257B5777-14F6-4B57-9324-00094B71D830 Q33302708-B476DF84-CA33-4B4B-8954-61FB524E54D2 Q33866383-19EE79DD-F7E7-4BF5-8806-818F99DF4645 Q33999294-A3AFE3E1-748A-48A6-B774-23D32AD94B7D Q34469014-2215BB44-087F-486B-9813-A4298B682C35 Q34551475-F66FFEE3-D220-4581-B226-97762D2A6ACF Q34686484-0961546D-E7FB-4048-BAB2-A48A99CD0442 Q34792158-00D57CAE-8DC2-43FD-B6EA-CC729D3E47F7 Q34892910-A660232A-3D9D-4B05-9AF3-4F5C48F2B8D2 Q35389163-823EBABA-EAA8-4D71-849B-FF482D8B0217 Q35575885-F90FCD2B-8323-45C2-9169-5B1691CAB667 Q35715916-5AC4CE04-F823-4816-A7E0-1613FF05A82C Q36643026-D6641E52-4314-4C55-A589-776021CEE785 Q36812170-97B45BE9-BBEE-4B43-B6D2-8BD5FC26793A Q37135387-7D71C0D2-1849-4B3B-8A0C-619BD4E92CE9 Q37182969-BB74E644-81A2-4592-91D7-DB444A375BB2 Q37222778-F7088DBF-CBC1-41EA-A371-61EABCF191EA Q37299982-FCD5DC8C-6EBA-484A-9DF8-A87203338222 Q37536973-1CB357E0-9E8D-486B-A84C-AEC97C9A0EA1 Q37626958-1DC0715E-8AC1-4E25-A408-B76BFE652FE1 Q41013952-99C3A619-C377-4CFB-AB7E-7F2CB19925AD Q41960527-9B808DDF-DB03-44E1-86A4-195345DADDA1 Q41970506-F1383C48-0AAA-4E10-A1A7-610547FFDD89 Q42160967-296DD0F7-5E6C-4F52-94D9-6E93C1D48503 Q42196088-9040F447-CE11-4CCE-91AC-1EF79E80C8F2 Q42547916-26D8303E-B043-4921-AD39-016B2626CAF0

P2860

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

http://www.wikidata.org/entity/Q34984098

description

2002 nî lūn-bûn

@nan

2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

@ast

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

@en

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

@nl

type

label

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

@ast

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

@en

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

@nl

prefLabel

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

@ast

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

@en

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

@nl

P1433

Q34984098-C78545CC-ECEA-436A-8080-5DBA8A3480F6

P1476

Q34984098-ABE63EF4-DD6F-4B8B-80A1-E1E06DA1B8B2

P2093

Q34984098-426EAAFA-36FF-4D5B-BFD1-4A871B7716EA

Q34984098-7B49C7AE-665D-4537-8CCB-59658BF6487F

Q34984098-8DA874C1-3C77-4C02-97CB-6F7A26414C64

Q34984098-9BED0B9F-A673-4E51-B992-BD08F2D21B4D

Q34984098-ACF1D7B6-01B2-445C-8D2B-C8C8F72AB806

Q34984098-B43E78CA-5C6D-4EB9-987A-6705DEDF3197

Q34984098-CC5DD1A1-0601-4E67-9E52-F98E64E02649

Q34984098-F5CFD01A-285D-473C-92D8-3211A59BDBF5

Q34984098-F7B3F86C-F3AB-4227-867D-34DD378A273F

P2860

Q34984098-038172D7-603E-412F-AAAE-585AECC409D6

Q34984098-105FE53F-1F2B-4B4A-AAA3-66FA20EEBEB6

Q34984098-1C1E8C60-7327-447D-9A8C-C4E8AFB5598E

Q34984098-20390184-B785-450C-9370-2AE1E946AE08

Q34984098-204693F3-6391-4141-9032-1B15B4F3917E

Q34984098-2090EE3F-D841-4274-82A2-FA8CF365D7E4

Q34984098-2185FA0C-DDA6-4974-8F87-65CFA27ABDEF

Q34984098-22AE6EE3-0340-4328-B1CF-63E4F652D553

Q34984098-246FBABA-1CFC-4772-8C1B-3FC5109A5B40

Q34984098-3013437C-E1DF-4983-BFBD-E96671A14DD5

P304

Q34984098-7FB13CF8-4C71-4C81-8DE1-F38870F3D5C0

P31

Q34984098-2EDC707A-81FF-4DE1-9E45-8FAB3FB1B784

P356

Q34984098-14920FDA-D77F-4E28-8F88-F3DB4D479013

P407

Q34984098-60CBCA83-057B-4161-8E86-FB784023268E

P433

Q34984098-FF84A723-976E-4AD7-B639-D45C898C075F

P478

Q34984098-00B8AAEC-DA52-418D-B6AE-67F7CDFFAB34

P577

Q34984098-E719F279-94B5-41B3-9609-960F66C15C64

P5875

Q34984098-450C8D07-2BD7-4FCB-A3D3-27D62D8344B3

P698

Q34984098-A21EEF68-4743-4BF4-91DF-5ECDDA66B0AB

P356

JHEP.2002.36989

P1433

P1476

Role of liver biopsy in management of chronic hepatitis C: a systematic review.

@en

P2093

Eric B Bass

http://www.w3.org/2001/XMLSchema#string

Geetanjali Chander

http://www.w3.org/2001/XMLSchema#string

H Franklin Herlong

http://www.w3.org/2001/XMLSchema#string

Kelly A Gebo

http://www.w3.org/2001/XMLSchema#string

Khalil G Ghanem

http://www.w3.org/2001/XMLSchema#string

Mark Sulkowski

http://www.w3.org/2001/XMLSchema#string

Michael S Torbenson

http://www.w3.org/2001/XMLSchema#string

Mollie W Jenckes

http://www.w3.org/2001/XMLSchema#string

Samer S El-Kamary

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data.

Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.

Pharmacological treatment of alcohol dependence: a review of the evidence.

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.

Liver biopsy in the mid-1990s: questions and answers.

The role of liver biopsy in hepatitis C.

Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha.

Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study.

Long-term administration of natural interferon-alpha in patients with chronic hepatitis C: relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus.

P304

S161-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/JHEP.2002.36989

http://www.w3.org/2001/XMLSchema#string

P407

P433

5 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11056247

http://www.w3.org/2001/XMLSchema#string

P698

12407590

http://www.w3.org/2001/XMLSchema#string